Japan · Series A startup

Who invested in The Phage

One round we have observed, with the 5 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

AIBiotechHealthcare

Raised 1 month ago

Funding summaryUpdated 26 Oct 2026

$3.6Mraised across 1 round since 2026, from 1 source

Latest round
Series A, $3.6MOct 2026
Led by
ITOCHU Technology Ventures
Investors
5 (1 led)
See who backed them

The rounds

  1. Oct 2026

Everyone who backed them

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 2 firms list The Phage as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.

G-STARTUPAcceleratorPer its own site
Vision Incubate Co., Ltd.VC firmPer its own site

Quick answers about The Phage

Who invested in The Phage?

The Phage's investors include ITOCHU Technology Ventures, Genesia Ventures, Fukui Capital Partners, Tokio Marine & Nichido Fire Insurance and Vision Incubate. ITOCHU Technology Ventures led its latest round.

How much has The Phage raised?

The Phage has raised $3.6M across 1 round since 2026.

When did The Phage last raise?

The Phage's most recent round was a Series A of $3.6M in Oct 2026, led by ITOCHU Technology Ventures.

What was The Phage's biggest round?

Its most recent round, $3.6M in Oct 2026, is also its largest on record.

Who backed The Phage first?

The Phage's first round on record, in Oct 2026, was backed by ITOCHU Technology Ventures, Genesia Ventures and Fukui Capital Partners and 2 others.

What stage is The Phage at?

The Phage's latest named round is a Series A, in Oct 2026.

Where is The Phage based?

The Phage is based in Japan.

Who led The Phage's rounds?

ITOCHU Technology Ventures led the Series A in 2026.

Companies like The Phage

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.